Quick Answer
Humacyte, Inc. reported Net Income of -$40.83 million for fiscal year 2025.
Humacyte, Inc. Net Income — Annual History
| Fiscal Year | Net Income | YoY Change |
|---|---|---|
| 2025 | -$40.83M | +72.5% |
| 2024 | -$148.70M | -34.2% |
| 2023 | -$110.78M | -825.8% |
| 2022 | -$11.96M | +54.8% |
| 2021 | -$26.48M | +60.2% |
| 2020 | -$66.52M | — |
Quarterly Net Income
| Quarter Ending | Net Income | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | -$17.51M | +55.3% | +53.5% |
| June 30, 2025 | -$37.66M | +33.5% | -196.2% |
| March 31, 2025 | $39.14M | +222.7% | +199.8% |
| September 30, 2024 | -$39.20M | -50.8% | +30.8% |
| June 30, 2024 | -$56.66M | -149.6% | -77.6% |
| March 31, 2024 | -$31.90M | +13.7% | -22.7% |
| September 30, 2023 | -$26.00M | -2.8% | -14.5% |
| June 30, 2023 | -$22.71M | -161.6% | +38.6% |
- Humacyte, Inc. showed an increase of +72.5% in Net Income compared to the prior fiscal year.
- Over the 2020–2025 period, Humacyte, Inc.’s net income has grown by 38.6% (from -$66.52 million to -$40.83 million).
- The most recent figure is from Humacyte, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 27, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: